CELIA Trial

Event

Phase 2 randomized controlled trial evaluating diranersen in early Alzheimer's disease

1 story

Experimental Drug Shows First-Ever Reduction in Tau Pathology and Cognitive Benefit in Early Alzheimer's Trial